genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2022
Rosetta Genomics
Cancer
Novel CRISPR Tool Activates Instead of Editing Human Immune Cell Genes
Industry News
Rosetta Genomics to Acquire PersonalizeDx
News
Rosetta Genomics Enters NGS Research Collaboration with Weizmann Institute
News
Rosetta Genomics, Marina Biotech to Tackle Dystrophies, Neuromuscular Diseases
News
Rosetta Genomics and Tel Aviv University Expand Relationship
Insights
People in the News
Cancer
Rosetta Genomics to Slash 35 Jobs to Focus on MDx Commercialization in the U.S.
Best of the Web
RosettaAntibody: Fv Homology Modeling Server
Cancer
Rosetta Genomics Nixes 20% of Global Staff
Industry News
Rosetta Genomics to Receive $4.5M in a Registered Direct Offering
1
2
3
Page 1 of 3
Scroll Up